These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
517 related articles for article (PubMed ID: 14691167)
1. Effects of TGF-beta2 in perfused human eyes. Gottanka J; Chan D; Eichhorn M; Lütjen-Drecoll E; Ethier CR Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):153-8. PubMed ID: 14691167 [TBL] [Abstract][Full Text] [Related]
2. Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma. Wordinger RJ; Fleenor DL; Hellberg PE; Pang IH; Tovar TO; Zode GS; Fuller JA; Clark AF Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1191-200. PubMed ID: 17325163 [TBL] [Abstract][Full Text] [Related]
3. Effects of latrunculin-B on outflow facility and trabecular meshwork structure in human eyes. Ethier CR; Read AT; Chan DW Invest Ophthalmol Vis Sci; 2006 May; 47(5):1991-8. PubMed ID: 16639007 [TBL] [Abstract][Full Text] [Related]
5. The effect of cytochalasin D on outflow facility and the trabecular meshwork of the human eye in perfusion organ culture. Johnson DH Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2790-9. PubMed ID: 9418732 [TBL] [Abstract][Full Text] [Related]
6. Ultrastructural and biochemical evaluation of the porcine anterior chamber perfusion model. Bachmann B; Birke M; Kook D; Eichhorn M; Lütjen-Drecoll E Invest Ophthalmol Vis Sci; 2006 May; 47(5):2011-20. PubMed ID: 16639010 [TBL] [Abstract][Full Text] [Related]
7. Pharmacologic disruption of Schlemm's canal cells and outflow facility in anterior segments of human eyes. Bahler CK; Hann CR; Fautsch MP; Johnson DH Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2246-54. PubMed ID: 15223802 [TBL] [Abstract][Full Text] [Related]
8. Retroperfusion studies of the aqueous outflow system. Part 2: Studies in human eyes. Ethier CR; Coloma FM; de Kater AW; Allingham RR Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2466-75. PubMed ID: 7591636 [TBL] [Abstract][Full Text] [Related]
9. Thrombospondin-1 in the trabecular meshwork: localization in normal and glaucomatous eyes, and induction by TGF-beta1 and dexamethasone in vitro. Flügel-Koch C; Ohlmann A; Fuchshofer R; Welge-Lüssen U; Tamm ER Exp Eye Res; 2004 Nov; 79(5):649-63. PubMed ID: 15500824 [TBL] [Abstract][Full Text] [Related]
10. Dexamethasone-induced ocular hypertension in perfusion-cultured human eyes. Clark AF; Wilson K; de Kater AW; Allingham RR; McCartney MD Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):478-89. PubMed ID: 7843916 [TBL] [Abstract][Full Text] [Related]
11. Adenoviral gene transfer of active human transforming growth factor-{beta}2 elevates intraocular pressure and reduces outflow facility in rodent eyes. Shepard AR; Millar JC; Pang IH; Jacobson N; Wang WH; Clark AF Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2067-76. PubMed ID: 19959644 [TBL] [Abstract][Full Text] [Related]
12. Morphological and hydrodynamic correlates in monkey eyes with laser induced glaucoma. Zhang Y; Toris CB; Liu Y; Ye W; Gong H Exp Eye Res; 2009 Nov; 89(5):748-56. PubMed ID: 19591828 [TBL] [Abstract][Full Text] [Related]
13. Blebbistatin, a novel inhibitor of myosin II ATPase activity, increases aqueous humor outflow facility in perfused enucleated porcine eyes. Zhang M; Rao PV Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4130-8. PubMed ID: 16249490 [TBL] [Abstract][Full Text] [Related]
14. TGFbeta2-induced changes in human trabecular meshwork: implications for intraocular pressure. Fleenor DL; Shepard AR; Hellberg PE; Jacobson N; Pang IH; Clark AF Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):226-34. PubMed ID: 16384967 [TBL] [Abstract][Full Text] [Related]
15. Effects of Salidroside on Trabecular Meshwork Cell Extracellular Matrix Expression and Mouse Intraocular Pressure. Fan Y; Guo L; Wei J; Chen J; Sun H; Guo T Invest Ophthalmol Vis Sci; 2019 May; 60(6):2072-2082. PubMed ID: 31091314 [TBL] [Abstract][Full Text] [Related]
16. Schlemm's canal and primary open angle glaucoma: correlation between Schlemm's canal dimensions and outflow facility. Allingham RR; de Kater AW; Ethier CR Exp Eye Res; 1996 Jan; 62(1):101-9. PubMed ID: 8674505 [TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic protein-7 is an antagonist of transforming growth factor-beta2 in human trabecular meshwork cells. Fuchshofer R; Yu AH; Welge-Lüssen U; Tamm ER Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):715-26. PubMed ID: 17251470 [TBL] [Abstract][Full Text] [Related]
18. Effects of ethacrynic acid on Schlemm's canal inner wall and outflow facility in human eyes. Ethier CR; Coloma FM Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1599-607. PubMed ID: 10359344 [TBL] [Abstract][Full Text] [Related]
19. Human trabecular meshwork cells express BMP antagonist mRNAs and proteins. Tovar-Vidales T; Fitzgerald AM; Clark AF Exp Eye Res; 2016 Jun; 147():156-160. PubMed ID: 27167364 [TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta2 utilizes the canonical Smad-signaling pathway to regulate tissue transglutaminase expression in human trabecular meshwork cells. Tovar-Vidales T; Clark AF; Wordinger RJ Exp Eye Res; 2011 Oct; 93(4):442-51. PubMed ID: 21722634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]